Genetic associations with longevity are on average stronger in females than in males
Yi Zeng,Huashuai Chen,Xiaomin Liu,Zijun Song,Yao Yao,Xiaoyan Lei,Xiaozhen Lv,Lingguo Cheng,Zhihua Chen,Chen Bai,Zhaoxue Yin,Yuebin Lv,Jiehua Lu,Jianxin Li,Kenneth C. Land,Anatoliy Yashin,Angela M. O'Rand,Liang Sun,Ze Yang,Wei Tao,Jun Gu,William Gottschalk,Qihua Tan,Kaare Christensen,Therese Hesketh,Xiao-Li Tian,Huanming Yang,Viviana Egidi,Graziella Caselli,Jean-Marie Robine,Huali Wang,Xiaoming Shi,James W. Vaupel,Michael W. Lutz,Chao Nie,Junxia Min
DOI: https://doi.org/10.1016/j.heliyon.2023.e23691
IF: 3.776
2023-12-22
Heliyon
Abstract:It is long observed that females tend to live longer than males in nearly every country. However, the underlying mechanism remains elusive. In this study, we discovered that genetic associations with longevity are on average stronger in females than in males through bio-demographic analyses of genome-wide association studies (GWAS) dataset of 2178 centenarians and 2299 middle-age controls of Chinese Longitudinal Healthy Longevity Study (CLHLS). This discovery is replicated across North and South regions of China, and is further confirmed by North-South discovery/replication analyses of different and independent datasets of Chinese healthy aging candidate genes with CLHLS participants who are not in CLHLS GWAS, including 2972 centenarians and 1992 middle-age controls. Our polygenic risk score analyses of eight exclusive groups of sex-specific genes, analyses of sex-specific and not-sex-specific individual genes, and Genome-wide Complex Trait Analysis using all SNPs all reconfirm that genetic associations with longevity are on average stronger in females than in males. Our discovery/replication analyses are based on genetic datasets of in total 5150 centenarians and compatible middle-age controls, which comprises the worldwide largest sample of centenarians. The present study's findings may partially explain the well-known male-female health-survival paradox and suggest that genetic variants may be associated with different reactions between males and females to the same vaccine, drug treatment and/or nutritional intervention. Thus, our findings provide evidence to steer away from traditional view that "one-size-fits-all" for clinical interventions, and to consider sex differences for improving healthcare efficiency. We suggest future investigations focusing on effects of interactions between sex-specific genetic variants and environment on longevity as well as biological function.